Skip Navigation


Cardiovascular Research Advance Access originally published online on November 21, 2007
Cardiovascular Research 2008 77(3):570-579; doi:10.1093/cvr/cvm073
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrowOA All Versions of this Article:
77/3/570    most recent
cvm073v2
cvm073v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Knock, G. A.
Right arrow Articles by Aaronson, P. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knock, G. A.
Right arrow Articles by Aaronson, P. I.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2007. For permissions please email: journals.permissions@oxfordjournals.org
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org.

Interaction between src family kinases and rho-kinase in agonist-induced Ca2+-sensitization of rat pulmonary artery

Greg A. Knock*, Yasin Shaifta, Vladimir A. Snetkov, Benjamin Vowles, Svetlana Drndarski, Jeremy P.T. Ward and Philip I. Aaronson

Department of Asthma, Allergy and Respiratory Science, School of Medicine, King’s College London, Room 3.20, Franklin Wilkins Building, Stamford Street, London SE1 9NH, UK

* Corresponding author. Tel: +44 020 7848 4297; fax: +44 020 7848 3743. E-mail address: greg.knock{at}kcl.ac.uk

Aims: We investigated the role of src family kinases (srcFK) in agonist-mediated Ca2+-sensitization in pulmonary artery and whether this involves interaction with the rho/rho-kinase pathway.

Methods and results: Intra-pulmonary arteries (IPAs) and cultured pulmonary artery smooth muscle cells (PASMC) were obtained from rat. Expression of srcFK was determined at the mRNA and protein levels. Ca2+-sensitization was induced by prostaglandin F2{alpha} (PGF2{alpha}) in {alpha}-toxin-permeabilized IPAs. Phosphorylation of the regulatory subunit of myosin phosphatase (MYPT-1) and of myosin light-chain-20 (MLC20) and translocation of rho-kinase in response to PGF2{alpha} were also determined. Nine srcFK were expressed at the mRNA level, including src, fyn, and yes, and PGF2{alpha} enhanced phosphorylation of three srcFK proteins at tyr-416. In {alpha}-toxin-permeabilized IPAs, PGF2{alpha} enhanced the Ca2+-induced contraction (pCa 6.9) approximately three-fold. This enhancement was inhibited by the srcFK blockers SU6656 and PP2 and by the rho-kinase inhibitor Y27632. Y27632, but not SU6656 or PP2, also inhibited the underlying pCa 6.9 contraction. PGF2{alpha} enhanced phosphorylation of MYPT-1 at thr-697 and thr-855 and of MLC20 at ser-19. This enhancement, but not the underlying basal phosphorylation, was inhibited by SU6656. Y27632 suppressed both basal and PGF2{alpha}-mediated phosphorylation. The effects of SU6656 and Y27632, on both contraction and MYPT-1 and MLC20 phosphorylation, were not additive. PGF2{alpha} triggered translocation of rho-kinase in PASMC, and this was inhibited by SU6656.

Conclusions: srcFK are activated by PGF2{alpha} in the rat pulmonary artery and may contribute to Ca2+-sensitization and contraction via rho-kinase translocation and phosphorylation of MYPT-1.

KEYWORDS Pulmonary circulation; Smooth muscle; Vasoconstriction/dilation; Tyrosine; Protein kinases; Prostaglandins; Rho-kinase

Time for primary review: 34 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Reproductive SciencesHome page
M. Phillippe, L. M. Sweet, D. F. Bradley, and D. Engle
Role of Nonreceptor Protein Tyrosine Kinases During Phospholipase C-{gamma}1-related Uterine Contractions in the Rat
Reproductive Sciences, March 1, 2009; 16(3): 265 - 273.
[Abstract] [PDF]

Home page
 Cardiovasc ResHome page
G. A. Knock, V. A. Snetkov, Y. Shaifta, S. Drndarski, J. P.T. Ward, and P. I. Aaronson
Role of src-family kinases in hypoxic vasoconstriction of rat pulmonary artery
Cardiovasc Res, December 1, 2008; 80(3): 453 - 462.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
M. Miron-Mendoza, J. Seemann, and F. Grinnell
Collagen Fibril Flow and Tissue Translocation Coupled to Fibroblast Migration in 3D Collagen Matrices
Mol. Biol. Cell, May 1, 2008; 19(5): 2051 - 2058.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.